E Ciafaloni

Summary

Affiliation: University of Rochester
Country: USA

Publications

  1. ncbi Mycophenolate mofetil and myasthenia gravis
    E Ciafaloni
    Department of Neurology, University of Rochester, New York 14642, USA
    Lupus 14:s46-9. 2005
  2. ncbi Pregnancy and birth outcomes in women with facioscapulohumeral muscular dystrophy
    E Ciafaloni
    Department of Neurology, University of Rochester, 601 Elmwood Avenue, Box 673, Rochester, NY 14642, USA
    Neurology 67:1887-9. 2006
  3. ncbi The hypocretin neurotransmission system in myotonic dystrophy type 1
    E Ciafaloni
    University of Rochester, Department of Neurology, 601 Elmwood Avenue, Box 673, Rochester, NY 14642, USA
    Neurology 70:226-30. 2008
  4. ncbi Delayed diagnosis in duchenne muscular dystrophy: data from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet)
    Emma Ciafaloni
    Department of Neurology, University of Rochester, Rochester, NY, USA
    J Pediatr 155:380-5. 2009
  5. ncbi Use of single strand conformation polymorphism analysis to detect point mutations in human mitochondrial DNA
    A Suomalainen
    Department of Neurology, Columbia University, New York, NY
    J Neurol Sci 111:222-6. 1992
  6. ncbi Effect of thymectomy on human peripheral blood T cell pools in myasthenia gravis
    G Sempowski
    Department of Medicine, Center for AIDS Research, and Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710, USA
    J Immunol 166:2808-17. 2001
  7. ncbi Mycophenolate mofetil for myasthenia gravis: an analysis of efficacy, safety, and tolerability
    M N Meriggioli
    Department of Neurological Sciences, Rush University, Rush Presbyterian St Luke s Medical Center, Chicago, IL 60612, USA
    Neurology 61:1438-40. 2003

Collaborators

Detail Information

Publications7

  1. ncbi Mycophenolate mofetil and myasthenia gravis
    E Ciafaloni
    Department of Neurology, University of Rochester, New York 14642, USA
    Lupus 14:s46-9. 2005
    ....
  2. ncbi Pregnancy and birth outcomes in women with facioscapulohumeral muscular dystrophy
    E Ciafaloni
    Department of Neurology, University of Rochester, 601 Elmwood Avenue, Box 673, Rochester, NY 14642, USA
    Neurology 67:1887-9. 2006
    ..The rates for low birth weight and total operative deliveries were statistically higher than the national rates in the general population. Worsening of FSHD was reported in 24% of gestations and did not usually resolve after delivery...
  3. ncbi The hypocretin neurotransmission system in myotonic dystrophy type 1
    E Ciafaloni
    University of Rochester, Department of Neurology, 601 Elmwood Avenue, Box 673, Rochester, NY 14642, USA
    Neurology 70:226-30. 2008
    ..Some patients with DM1 show sleep-onset REM, similar to that observed in narcolepsy. Narcolepsy is characterized by impaired hypocretin (Hcrt) neurotransmission...
  4. ncbi Delayed diagnosis in duchenne muscular dystrophy: data from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet)
    Emma Ciafaloni
    Department of Neurology, University of Rochester, Rochester, NY, USA
    J Pediatr 155:380-5. 2009
    ..To identify key factors for the delay in diagnosis of Duchenne muscular dystrophy (DMD) without known family history...
  5. ncbi Use of single strand conformation polymorphism analysis to detect point mutations in human mitochondrial DNA
    A Suomalainen
    Department of Neurology, Columbia University, New York, NY
    J Neurol Sci 111:222-6. 1992
    ..Using SSCP analysis, we also detected a new polymorphism in 1 patient. Thus, SSCP analysis can be applied to search effectively and rapidly for point mutations or polymorphisms in mitochondrial DNA...
  6. ncbi Effect of thymectomy on human peripheral blood T cell pools in myasthenia gravis
    G Sempowski
    Department of Medicine, Center for AIDS Research, and Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710, USA
    J Immunol 166:2808-17. 2001
    ..In contrast, there was no significant effect of thymectomy on absolute numbers of naive PB T cells. Thus, in MG, removal of a thymus with active thymopoiesis resulted in a significant fall in PB TREC(+) T cells postthymectomy...
  7. ncbi Mycophenolate mofetil for myasthenia gravis: an analysis of efficacy, safety, and tolerability
    M N Meriggioli
    Department of Neurological Sciences, Rush University, Rush Presbyterian St Luke s Medical Center, Chicago, IL 60612, USA
    Neurology 61:1438-40. 2003
    ..Quantitative strength testing performed on the majority of patients before and after treatment also improved. Side effects to MyM were observed in 27% of patients but required discontinuation in only 6%...